ProShare Advisors’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.3K | Sell |
|
|||||
|
2025
Q1 | $111K | Sell |
|
|||||
|
2024
Q4 | $235K | Buy |
|
|||||
|
2024
Q3 | $139K | Buy |
|
|||||
|
2024
Q2 | $101K | Sell |
|
|||||
|
2024
Q1 | $161K | Buy |
|
|||||
|
2023
Q4 | $203K | Buy |
|
|||||
|
2023
Q3 | $99.2K | Buy |
|
|||||
|
2023
Q2 | $152K | Buy |
|
|||||
|
2023
Q1 | $124K | Sell |
|
|||||
|
2022
Q4 | $150K | Buy |
|
|||||
|
2022
Q3 | $185K | Sell |
|
|||||
|
2022
Q2 | $138K | Sell |
|
|||||
|
2022
Q1 | $197K | Buy |
|